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Influence of Preoperative Pulmonary Artery Pressure on Mortality
After Heart Transplantation: Testing of Potential Reversibility of
Pulmonary Hypertension With Nitroprusside Is Useful in Defining a
High Risk Group
ANGELIKA COSTARD-JACKLE, MD, MICHAEL D . FOWLER, MB, MRCP. FACC
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Patients with pulmonary hypertension are al risk of developing
total right heart failure after hear) transplaalafioa, to evaluate
Ibis risk potential, candidates for heart transplantation are
screened by measuring rest right heart pressures and the response
to ldlroprusride. To lest the validity of this approach . !I . in°e-
ence of pretransplaoation right bean c theteriaatian data on
outcome after transplantatlua was amlyred in 29y of 301 eoacee-
utive palieats.
Patients with a pulmonary vascular resistance >2 .5 Wood
units measured at baseline studs had a 3-month mortality rate of
17 .9% compared with 6 .9% en patients %ilh resistance 52,5 units
(p < 0.02). Patients with a pulmonary vascular resistance X2 .5
units at baseline study could he difereartiated further according to
their hemodynamie response to nilroprltsside : these whose resis-
taace could be reduced to m2 .5 units with a stable systemic systolic
Most patients with advanced heart failure under consider-
ation for heart transplantation have at least moderately
elevated pulmonary artery pressure
. Severe pulmonary hy-
pe-tension is considered a contraindication to orthatopic
transplantation because of the risk of acute right ventricular
failure when the right ventricle of the grafted heart is unable
to adapt to significant pulmonary hypertension in the imme-
diate postoperative period (1-3).
Recently, several studies
(4-6) have confirmed that elevated pulmonary vascular
resistance is an independent risk factor for mortality both
early and late after trans ;9lanlation .
However, some patients with moderate to severe pulmo-
nary hypertension have successfully indergone transplants'
Lion . In these patients, serial hemodynamic measurements
after transplantation detnohstrated a progressive decrease in
pulmonary artery pressure, illustrating the potential rcvera.
ibiliity of pulmonary hypuntettsiun (7-121, Hemudynamic
measurement of the potential reversibility of pulmonary
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pressure -85 mm Hg had a 3-month mmtall!} rateofonty, 3 .8%.
In coataan, patients whose pulmonary vaseolvr resistance could
unit he
reduced
to <2.5 units, and those whose resistance could be
reduced to 52,5 units but only at the expense of systemic
hypotensioo (systoic pressure <85 mm Hg) had a 3-mouth
mortality rate of *.6% and 27.5%, respectively. Furthermore,
all 10 patients who died of right heart failure belonged to the latter
two groups.
These findings confirm the value of right heart benadynamic
measurements and the response in ntlropru side In predicting
early mortality after heart transplantation and, in particular,
.rnrtality due to right heart failure. Valid risk stratification based
on the nemodynamic response to nitroprusside requires consider-
ation of the concomitant change in systemic pressure .
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hypertension by administration of 1009 oxygen, nitreglyc
crin or nitroprusside is frequently performed in evaluating
candidates for heart transplantation (6,13-15)
. However, no
systematic study has been performed of whether then,
maneuvers aid in assessing the risk of acute graft right bean
failure and the attendant early mortality after transplanta-
tion.
Al Stanford . candidates for heart transplantation undergo
right heart catheterization and, for those with elevated
pulmonary vascular resistance or systolic pulmonary pres-
sure, or both . an
attempt is made to evaluate the reversibility
of pulmonary hypertension with a graded nitroprusside
infusion. The data obtained have been reviewed and retro-
spectively analyzed in 393 of 301 consecutive transplant
recipioots to evaluate the relation between right heart hemo-
dy nannies . response to nitroprusside and outcome after heart
transplantation .
Methods
Study patients. Between December 1980 (when cyclos-
porine was introduced to the immunosuppressive regimen)
and July 1999, 301 New York Heart Association functional
class IV patients underwent heart transplantation at Stan-
ford University Medical Center . The patients (231 men and
(719.Iron,sot53 10
IACC Vol . 19. No. I
Jer rorv :992 .48-u
70 women, ranged in age from 9 months to 60 years (mean 39
4 years)
. The primary diagnosis was cardiomyopathy in
'54 patients, end-stage left ventricular failure from coronary
artery disease in 112, congenital heart disease in 13, post-
partum cardiomyopathy in 6 . valvular heart disease in 4 .
adriamvcln-induced cardiomyopathy in 3, rstrictise hewn
disease in 3, sarcosdosis in 2 . acute n:vocarditis in
3 arid
amvloidosis in I .
Right heart catheteriratiun, Two hundred ninety-three of
the 30!
patients underwent rigbl heart cathe:,-rization in the
catheterization laboratory at Slaniord Umceroy Hospfmt :
under fluoroscopic guidance, a 7F balloon flotation pulmo-
nary artery catheter was advanced to the pulmonary occlu-
sive position (usually by way of the ju€ular vein)
. A cannula
inseried into a brachial or radial artery was used for systemic
pressure recordings and for repeated arterial blood sampling .
Micron transducers were used to record an a Hewlett
Packard recorder these pressures (in mm tlgr mean right
atria, ; pulmonary artery systolic, diastolic end mean (PAP
mean)
; pulmonary capillary wedge (PCWP) ; and systemic
arterial systolic, diastolic and mean pressures . Cardiac out-
put (CO) was measured by the Fick method nd normalized
for body surface area (cardiac i ndex. C U .
Pulmonary rasraloe resistance (PVR, Wood units) is
calculated as
(PAP mean - PCWPI
PVR -
CO
Pulmonary vuartdur resistance index (PVRI . units x ill is
calculated as
(PAP mean - PCW'PI
PVRI =
CI
Transp/rlmonarv Rrodienr ITPG . mm Hg1 is calculated as
TPG = PAP mean -
PCWP.
Patients with pulmonary vascular resistance >2 .5 units or
systolic pulmonary artery pressure >40 mm lig. or both .
received a graded nitroplssside infusion
to evaluate revers-
ibility of pulmonary hypertension .
Nitroprusside infusion. An intravenous nitroprussidc in.
fusion was started at a dose of 25 to 50 oglmin . The dose was
increased rapidly and hemodynamic measurements were
obtained during the 5th min after every dose increase . uhtil
there was a clinically significant reduction in mean arterial
pressure or a reduction of pulmonary vascular resistance to
=2 .5 units and a reduction of systolic pulmonary artery
pressure to <40 mm Hg . For repeated determinations cf
cardiac output, only arterial and mixed venous blood sam-
ples were collected serially; oxygen consumption was rou-
tinely calculated from results of an expired gas collection at
baseline study
.
Evaluation of catheterlratinn data and Correlation with
efinfeal course . Catheterization data obtained before trans-
plantation, including hemodynamin response to nilroprus-
C05TARD-JACKLE AND etiWLla
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Figure 1. Cause of demh in the tsl 3 months alter heart transplan-
tation in 301 consecutive patients CVA = cerebrovascular anci-
dem : PF = pulmonary embolism ; PHT = pulmonary hypertension :
RHF = ngha heap failure .
side infusion, were reviewed and correlated with the pa-
tient's clinical course after transplantation . Analysis
included incidence of early postoperative mortality (defined
as death =90 days after transplantation) and presence or
absence of significant right heart railure. Postoperative right
heart failure was defined as significant when pulmonary
vasodilators were required in conjunction with clinical evi-
dence of right ventricular dysfunction and failure . A cause of
death was assigned to each patieot who died after transplant-
ration . Whenever possible, the assigned cause of death was
based en autopsy findings; when these were not available, it
was based on all available clinical and laboratory data .
Results
Survival rates and causes of death (Fig. I) . Of the 301
patients, 39 died within 90 days, 7 died within 3 to 6 months
and 12 died within 6 to 12 months after heart tmnsplantalbn,
corresponding to a survival rats of 86 .7%,
84.4% and 80.4%
at 3 . 6 and 12 months, respectively . after transplantation .
The most common cause of early (090 days) postoperative
death was infection, accounting for 43 .6% of deaths, to[-
lowed
by acute rejection (15 .4% of deaths) . Twenty-six
percent of the deaths were due to pulmonary hypertension or
right heart failure, corresponding to an overall mortality rate
due to pulmonary hypertension or right heart failure of 3.3%
(10 of 301 patiene0.
Clinical
right heart failure. In addition to the patients
who died of irreversible right bean failure or pulmonary
hypertension. 10 patients had a postoperative course com-
plicated by clinical signs of right heart failure, necessitating
prolonged inotropie and vasodilator support given intrave-
nously . Four of these patients were successfully treated with
prostaglandin E ; another four died 590 days after trans-
plantation because of infection .
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Table 1
. Hie cli0e Hemodynamic Variables in 288 Patients
Cl = cardiac indes: POP,,,,, = mean par -V artery pressure.
PAP,,,, = systolic pulmonary' onto . prestan : PVR = pen.-. .ascelor
enlance: PVRI = pulmomry
-._d,
rninence in," . RA,,,,,,, -
v rsm
cm
e
,
.rght elriel pressure. RVEDP n oFI cnaieulnr ead-dimlivit line
SAP„,,,,,
-mean systemic angry pressure'. SAP,,,, =synielic syointucanery
pressure: TPG `-
.-PA.-)
gradient .
Preoperative right heart hemodynamirs at baseline study
(Table 1). Right hears calhelenzation was performed in 293
patients
. Five of these patients (including one "bodied early
after transplantation because of right heap failure)
were
dependent on intravenous isotropic support at the lime of
preoperative evaluation. so that no true baseline data for
nitroprusside were available . The baseline hemodynamic
data in the remaining 288 patients are summarized in Table I .
Cardiac index ranged from 0 .4 to 5 literslmin per m2 (mean
2 0
.8).
Pulmonary vascular resistance (Table 2) . The pulmonary
vascular resistance, calculated in Wood units, ranged from
0.2 to 13 .41 mean 3 .2'- 2 .11 . Figure ?shows the distribution
of baseline values for pulmonary vascular resistance in
relation to 3-month mortality
. Table 2 summarizes the out-
come for transplant patients according to different threshold
values . A total of 145 (50,4%) of 288 patients had a baseline
pulmonary vascular resistance value >2 .5 units . Of these
patients, 26 I17,91e) died 2690 days after transplantation,
compared with In (6.99c) who died early postoperatively
among 143 patients with a baseline pulmonary vascular
resistance w2.5 units (p < 0 .02). All 9 patients who died
early after transplantation of pulmonary hypertension or
right heart failure, as well as all 10 patients who developed
right heart failure postoperatively but survived, had a base-
line pulmonary vascular resistance >2 .5 units. A higher
pulmonary vascular resistance threshold ( .85 vs . >5 resis-
tance units and O8 vs . >8 units) revealed a higher percent of
early
postoperative deaths in the groups with higher values
(I I deaths [22,9551 in 48 patients with a resistance level >5
units and 2 deaths [22 .241; in 9 patients with a resistance
level >8 units). However, among the nine patients who died
of right heart failure, six had a pulmonary vascular resis-
tance 55 units and all nine had a level 58 units, demonstrat-
ing loss of sensitivity if the pulmonary vascular resistance
threshold was set higher than 2 .5 units .
Pulmonary vascular resstance index . This index ranged
from 0 to 28 .9 resistanre index units (mean 5
.7 ± 3
.8) .
Teble 2 . Pulmonary Vn.robr Resistance, Systolic Pulmonary
Artery Pressure and Transpalmnnary Gradient According to
Dillerenl Threshold Values
1300,, 65
D,. la
Snrwved
r+o. of
truth, widen So MY,
RHF.PHT 3RHFI
Pis . Na .•
pAnlue
In..)
I.-
P values compare deaths m patients whose hemodynamic variables were
sr or below the threshold value nosh,6nu whose variables were h4hnr than
this value. PHT = pulmonary hypeneosion : Pis
. = patients : RHF = tight
loran failure . Other abbreviations and units as in Table 1 .
Among 130 patients with a pulmonary vascular resistance
index >5 index units, 23 died 090 days after transplanlatien .
The mortality rate of 17 .7% is significantly higher (p < 0,05)
than that of the 8.6`, (13 deaths) in the 151 patients with a
pulmonary vascular resistance index _5 index units . Two of
the nine patients who died w90 days after transplanla0on as
a result of pulmonary hypertension or right heart failure had
a pulmonary vascular resistance index <_5 index units and all
nine patients with clinical right heart failure belonged to the
group with a resistance index s5 index units . Data far
patients with an index 08 versus >8 index units were also
examined. The mortality rate in the group with the higher
index (10 deaths among 56 patients, 17
.9%) was sdnitar to
that obtained in the group with the higher index as defined by
a pulmonary vascular resistance index of >5 or ea5 index
units. However. the upper threshold of 8 resistance units
failed to include seven of nine patients who died of pulmo-
nary hypertension or right heart failure and three of nine
patients with postoperative right heart failure, all of whom
had a pulmonary vascular resistance index =8 units .
Systolic paintorarv artery pressure ranged from 14 to
88 mm Hg (mean 49 * 13) . Of 293 patients, 135 (4695) had a
systolic pulmonary artery pressure >50 mm Hg. Of these
Mean Range
Cl fliterslmin per mtl 2 _ 01 0.4 to S
SAP,,,, Imm Hgl 97 _ H 65 10 135
SAP„,,- non Hill 76 x 10 55 m 110
RA,,,,,, Iron Hg)
I I z 4 6 W
31
RVFDPImmllgl
1307 0to43
PAP—, I!nn Hg1 49 a IJ 14 to 88
PAP— (am H61 36 _ 9 9 to 58
PVR (Word anus) 32 5 L1 0.2 to 13 .4
PV81 (Wood units x m'1
5.7 a 3
.8
a m tax
TP(J onto Hg)
1016 01037
PVR _-2 .5
W3 10 69 "0 .01 0 0
PVR='2 .5
145 26 17 .9 9 10
PVC-> Set _ As NS
PVR >5 48 11 211 3
PVR=1 2911 34 12.1 NS 9
Pl'R-8 9 2 122 0
PAP - ,s:u 67
7
10.4 V5 a I
PAP, ,. >40 225 29 12.9 9 9
PAP,- ::M
157
1)
8
.3
=10
.05 I 3
PAP>s0 135 23 17 8 7
PAP-, °6@
235 -- 9.4 "0.001
6
PAP.,,,
>60 57
14 24.6
3
TP5
.10 163 17 9.4 vs a 1
TPG'In
117 19 24.6 5 6
TPG--11 14,1 27 117 >Do ,
5
TPG > ;5 9 21) 4
PVRI v
1
151 13 8 .6 15.00 3 0
PVRI >5 139
1
-3 17 .7 9
P0171 °°-R 27.5 25 11 .6 NS
3
PVRI >8 55 10 179
_
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Baseline PVR
Figure 2 . Influence of baseline pulmonary vascular resistance
(PVR) values an }month mortality after heart iamplantstion
studied bas = patients who died within 3 months after transplar-
tation : sml(d bars = patients who survived -3 months,
patients . 23 died <90 days after transplantation, which is a
significantly higher mortality rate (!7%l than that in the
group with a systolic pulmonary artery presdoh =50
mm
Hg
(8.3%, p < 0 .05) . Among the 9 patients who died of pulmo-
nary hypertension or right heart failure . I patient had a
systolic pulmonary artery pressure =5O mm Hg, as did 3 of
10 patients with postoperative right heart failure . A higher
threshold of 60 mm Hg revealed a higher early posoperative
mortality rate in patients with an elevated pressure (24 .6%) :
however, 6 of 9 patients who died of pulmonary hyperten-
sion or right heart failure and 5 of 10 patients with pastup-
erative right heart failure had a systolic pulmonary artery
pressure s00 mm Hg .
The franspulmonary gradient ranged from 0 to
37
mm Hg
(mean 10 ± 6). A threshold of 15 mm Hg separates the
groups at low and high risk for early postoperative mortality
(transpulmonary gradient <I5 mm Hg ; 3-month mortality
rate 11 .3% vs. transpulmonary gradient >15 mm Jig,
3-month mortality rate 20%; p < 0 .02). However . measure-
ment of the transpulmonary gradient did not differentiate
between patients at risk of death from pulmonary hyperten .
sion or right heart failure early after transplantation ; there
Table S. Camulative Data From Baseline Hemodynamic Data and the Response to Nio-opnsssidc
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were five early postoperative deaths from these causes in
patients with a transpulmonary gradient sl5 compared with
four deaths in patients with a transpulmonary gradient
>15 mm Hg.
Hemodynamic rote- to nitroprusside fl'able 3) . A total
of 150 patients received nitroprusside infusion ; 135 had a
pulmonary
vascular resistance >2 .5 units and systolic pul-
monary artery pressure >40 mm Hg, 10 had systolic pulmo-
nary artery pressure >40 mm Hg and a pulmonary vascular
resistance `-2 .5
and 5 patients were dependent on a low dose
of nitroprusside given intravenously at preoperative cathe-
terization and therefore no baseline data were available .
Patients were divided into three groups according to their
hemodynamic response to nitroprusside (Table 3) . Group A
consisted of 32 patients whose pulmonary vascular resis-
tance could not be decreased to <2 .5 units; Group B
consisted of 40 patients whose pulmonary vascular resis-
tance could be lowered to s2,5 . but only at :he expense of
severe systemic hypotension (systolic arterial pressure
s85 mm Hgi and Group C consisted of 78 patients whose
pulmonary
vasctdar resistance could be lowered to <-2.5
without concomaant severe systemic hypotension . main-
taining a systolic arterial pressure e85 mm Hg. Among the
78 Group C patients who showed reactivity of pulmonary
hypertension . only 3 (3 .8%) died ±90 days after transplan-
larian . In contrast . 11 patients (27.5%) in Group B and 13
patients
(40 .5P01
in Group A died
. Moreover, all patients
who died of right hart failure or pulmonary hypertension
belonged to Group A (3 of 32) or Group B (7 of 40) . In
addition . all patients who developed but survived posloper
.save right heart failure were in Group A (n = Ill or B in = 2) .
I(frenmdraamic data at baseline study and the data after
nirrapruusisr infusion are summarized, the s,rtnbincd data
can be used to drone two groups (Fig
. 3) : patients at high and
patients at considerably lower risk of death early after
transplantation . Patients at high risk included those whose
pulmonary vascular resistance could not be decreased to
<2 .5 units with nitroprusside (Group A) and those in whom
such a decrease was achieved only al the expense of severe
systemic hypoteasion (Group B). Patients at lowerri5k were
those who '-hocred
a signtfieanm reduction in pulmonary
vascular resistance but maintained stable systemic pressure
after nitroprusside infusion (Group CI and these whose
baseline pulmonary vascular resiltanee was m .5 units and
`Early
poswperatisu --
r compliu>rd by st :ceol right he ,e Oiture
. Abbrcviatiun, end units as in Tables I
and
2 .
Grasp
nasesse
PVR
Response to Nitropmsside
No . of
Pte.
Deaths Within
90 Days
(no. :kl
Deals,
the m
RHF1PHT
rno.Unt
survived
RHF•m o.;PVR SAP_,
4
> 2 5
>2
.5 -
31, 13
:40.6 3:9 .4 8
0
>15 a t.5 -85 40 11 -7.5 7 ;17 5 7
1: X2.5 5t.5 183 78 3 :3 .8 0 0
D <2.5 140 10 :6.9 0 0
52
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Figum 3
. Thrcc•I aonlh mortality after transplantation : dificrentia-
tioa of low and high risk groups according to pienperalivc pulmo-
nary hypertension. Group A = patients whnse pulmonary vascular
resistance could no[ be decreased to <2S Wood units in = 32):
Group 9 -
patients whose pulmonary vascular re
.s
i .stance could be
reduced to <2 .5 Wood units at the expense of severe systemic
hypotensidn in = 40) ; Group C = patients whose pulmonary
vascular resistance could (n = 78) be loweted to <_2 .5 units without
severe systemic hypotension : Group D - patient, whore pulmonary
vascular resi.+lance was <2 .5 units at baseline. Other abbreviations
as in Figure I . Hitched liars = deaths due to right heart failure and
pulmonary hypertension ; solid ban = deaths due to other causes .
did pool receive nitroprusside (Group Dl . The high risk group
had a five to six times higher early postoperative mortality
rate (33 .3 vs
. 6%; p < 0,OW1). Font'-t .vo percent of deaths
in the high risk group (10 of 24) tsars due to pulmonary
hypertension or right heart failure resulting in an mortality
rate due to right heart failure or pulmonary hypertension of
13 .9'* in ibis group
. Moreover, an additional 15% of these
high risk patients developed, but survived, postoperative
right heart failure .
Trlble 4 compares clinical data aid herrrodvnamie
'aria-
Her
is thaw rn
o groups
ifparienrs. There were no 50405ti-
cally significant differences between the high and low risk
groups in recipient or donor age and gender, ischemic time,
wailing lime for transplantation, .donor.recipient a eight mis .
match and diagnosis . .A
statistically significant I
. :gher per-
cent of patients at high versus low risk were debcndent on
intravenous inotrapic support before transplaoth
.ion, re-
flecting the overall poorer preoperative condition of patients
in the high risk group. Patients in the high risk group had
statistically significant higher values for systolic and mean
pulmonary angry pressure, pulmonary vascular resistance
and index
. Iranspulmonary gradient and systemic arterial
systolic pressure
. However . there was significant overlap in
values between the high and low risk groups . Therefore,
differentiation between patients at t :gh and low
risk based
on the henlodynamic response ant nitroprusside infusion
cannot be predicted from baseline hemedyntlmics alone .
Some patients in the low risk group had a baseline pulmo-
nary vascular resistance as high as 13
.4 units that could be
lowered to <2
.5 units while stable systemic ptesserm was
'No sopporstimravev0us supponlimmaortic batten rump or left v0Rneular chid 4ruirn ICoornery artery
discaseiidiopolhic choice ca*divmyopathyrcongenital hear direawhthcr . PordiEeremintion trlaren high hod I-
risk groups. See Figure 3 . Abbteuiations as in Table I .
Table 4. Demographic and Hemodynamic Data of Patients in the High and Low Risk Groups
High Risk to =72) Low Kink In =2181
Mean
Range Mean Range
to Value
Dancgnphic deu
Recipiem age Iyeem 39 - 16 9'.0 39 13 210 w
Wnitine time id, sl a1 56 o to 247 41 ' 55 0 to 291
I'd-lc lime-i
.)
127 t 50 3810 2_33 140 n 54 181.322
Donor age (parrot e3 8 bin 4-I _. e 8 2 In 4n
Wright M"hertehtkgl -t L 12
--1n23
- 2 a II -341027
RrcipienlgenderlhllFllh1 72128 79121
Dual, lsndcrIWFI171 8019 82118
f:'econdilinn' ISH 6513111 02(13 1 5 <n.w5
DlagROSSr 39149'48 36!5115,6
Hemvdynomic date
Cardiac octet Ill-'min per nc5 r 1 .9 • 1 .1 0 .41E 18 n7 O7 to 5
SAP_, (mm Ngl 93 n It 75 In 130 99 z 14 651 . US <0 .40
SAP_ lnlm us, 75 _ 9 55 to 110 76 a 10 55 to III
PAP,,,, tram R€1 56 11 76In 62 47 _ 13 1410 88 <0.001
PAP,,,,, Imm 1111 1 4007 26to56 34!9 9ta58 <0071
Pt'Riunisl 4 .9 ` 2 .1 2,61E 11.4 2,7 0. 1 .7 0.210 13 .4 <0.001
pVRl loops
a
frI s .I x 36 1 .8Ia I9.5 4 .913 .6 01028 .8 <1170 I
TPGtmmHta 14 e6 3to37 915 ara25 <O.Ig1
Lori' v ..i 19. No. I
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maintained, whereas some patients had a baseline pulmo-
nary vascular resistance as low as 2 .7 Lairs that could not he
de-creased without systemic pressure compromise.
Discussion
Elevated pulmonary vascular resistance told prisittransplan.
Lotion mortality . Resistant pnlmnnary hypertension has long
Leon identified as a major cause of early mortality (1-31 .
all-rough this concept has only mcentI been systematically
evaluated . Kirklin ct at . (51 anaryaed the outcome in 63
patients who vat l racnl heart transph,mation r' ' found an
elevated pulmonary vascular resistance (a be the most
important risk factor for both catty and tale mortality . Our
data confirm the importance of assessing baseline heotody-
namics: patients with a baseline pulmonary' vascular resis-
lance >2 5 units have an approximately twofold greater risk
of dying -90 days postoperatively . compared wah patients
with a pulmonary vascular resistance °--' .5
unhs at baseline
study . Furthermore, till patients who died of pulmonary
hypertension or right hen,', failure early after transplanta-
tion, as well as all sot . . tug patients whose early pos:opee-
alive course was cotnalicatad by right heart failure . had a
pulmonary vascular resistance >'.'s units . However . an
elevated baseline pulmonary vascular resistance does not
preclude a successful outcome after Iransplantation- Of 145
patients with pulmonary vascular resistance 02 .5 units . I 11)
survived the early postoperative period . The accuracy of
baseline pulmonary vascular resistance in duterentialing
between low and high risk patients could not oe improved by
changing the crilic'd resistance threshold. Thresholds >2 .5
units revealed a higher percent of patients wi'
:; :n elevated
pulmonary vascular resistance who died early after opera-
tion Ithat is . the higher thresholds yielded greater specificity
in detecting patients at risk of premature death) but sensi-
tivity was reduced . Several patients who died early after
transplantat ion of right heart failure or pulmona, y hyperten-
sion or developed clinical right, heart failure postoperatively
had a baseline pulmonary vascular resistance below a
threshold of 5 or 8 units .
6ksated pulmonary vascular resistance versus pulmonary
hwpertension- h was recently suggested that use of a pulmo-
nary vascular resistance index, which corrects for individual
variations in size, as a treasure of pulmonary hypertension
or use of the transpulmanary gradient might be superior in
identifying patients at risk of premature death after trans-
plantation 10,15). These findings could not be confirmed by
our data ; we did find that a pulmonary vascular resistance
index with a threshold of 5 index units, a transpulmonary
gradient with a threshold of 15 mm Hg at a systolic pulmo-
nary artery pressure with a threshold of 50 mm Hg also
allowed identification
old group of patients with significantly
increased risk of early mortality, but with a specificity no
higher than that of pulmonary vascular resistance . More-
over, a pulmonary vascular resistance with a threshold of 2 .1
units identified all 9 patients who died of right heats failure
r(1STARI7-JACKLEANtFOWLER
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and till IU o vieOIs who developed clinical right heart failure
peatupuatively . whereas use m"a pulmonary vascular resis-
tance
index !threshold 5 units), the transpatmenary, gradient
Ithreshold IS mm lie) or the systolic pulmonary artery
pres,ur
: threshold 50 mm Hgl dtsl nut idoatify sortie patiunts
who had values below the threshold but who died of or
developed right heart failure early ptetopuratively . Thus,
our data indicate that pulmonary vascular resislanee with a
threshold of 2
.5 antis identifies patients at high risk of early
postoperative death with an accuracy similar to that of [he
alternative hasetinr measures of pulmonary hypertension.
hut
i, superior in specifically identifying those at risk of
death from right heart failure postoperatively and therefore
should he used preferentially for this assessment .
Role of hemodynamic response to nitroprusside in eslimat
•
ing risk of transplantation . The potentia: of nitroprusside m
reduce pulmonary hypertension has long been known (16-
18) .
As
early as 19'71 it was suggested (1) that the hemody-
response to nitroprusside could be used to differen .
riutt between fixed and reversible pulmonary hypertension,
selecting patients with pulmonary hypertension for trans-
plantation . and since then, vasodilator studies (3,13) have
been recommended as a potentially useful tool in selecting
candidates far transplantation. Our analysis confirmed the
utility of die hemudynamic response to nitroprusside in
estimating the risk of transplantation in patients with ele-
vated baseline pulmonary vascular resistance. We found that
the hemalynamtc response to nitroprusside identified pa-
itents at high risk of It dying early after transplantation
13-month mortality rate . 33.3%1 ; 2) dying early after opera-
tion of right heart failure (13
.9%)
; and 3) developing right
hcarr taaIuer after operation 115%) . Patients at risk include
those whose pulmonary vascular resistance could not be
reduced to <2 .5 units and also those whose pulmonary
vascular resistance could be reduced to <l.5 Units only at
the expense of severe systemic hypotension (systolic pres-
sure <85 mm Hg) . These findings highlight the importance of
considering the concomitant change in systemic pressure
when interpreting the hentalynamic response to nitroprus-
side .
Conversely. the hemodynamic response to nitropruside
could also be useful in identifying a low risk group . FHtienl•:
whose pulmonary vascular resistance was reduced with
nitroprusside to <2 .5 units while a stable systolic pressure
a85 mm Hg was maintained had an overall early posnoper-
ative mortality rate of only 3 .8%, and can therefore be
classified as having a risk of early postoperative death as low
as that of patients with normal pulmonary vascular resis .
tance at baseline study .
Some patients with a baseline pulmonary vascular resis-
tance as high as 13 .4 units responded fully to nitropniesai .
whereas the only mildly elevated pulmonary vascular resis-
mnce in others did not change. These data demonstrate that
response to nitroprusside, and thus potential reversibility of
n1dmnnary hypertension, cannot be predicted from baseline
data .
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The cause oft he higher rate among patients with pulmo-
nary hypertension of early postoperative dealt caused by
factors other than right heart failure or pulmonary hyperien .
lion is not clear . Many of these patients' general failure to
thrive may increase the susceptibility to fatal infection
.
Preoperative pulmonary hypertension was recently been
reported (t2,16) to he a risk factor for posttransplanlation
pulmonary infection . In our study, 4 of the 10 patients who
developed significant right heart failure postnperatively died
of infection s90 days after transplantation .
Prophylactic treatment. Our study did not include any
patients who had heterotopic heart transplantation . The
benefit of such treatment to patients with pulmonary hyper-
tension was recently questioned (12)
.
and overall survival
rates reported in the registry of the International Society for
Cardiac Transplantation are generally worse than those for
anhulopic transplantation . Prostaglandin E I has been used
successfully to treat lire-threatening postoperative pulmo-
nary hypertension in patients unresponsive to standard
therapy (19,201, and its value in reducing perioperative and
postoperative mortality is now being studied . If these results
are promising + prophylactic treatment of patients at high risk
ofdeveloping. right hear failure in the perooperative and
early postoperative periods might he beneficial .
Conclusions. Our data confirm the utility Itfaicasurement
of right hears hemodynamic variables in the evaluation of
risk in candidates for heart transplantation.
Our
data do not
indicate how many patients rejected for cardiac transplanta-
tion on the basis of more severe pulmonary hypertension
might have fared had they undergone cardiac transplanta-
(ion. But they show that even among patients whose pulmo'
nary hypertension and responsiveness to nitroprusside were
considered acceptable for treatment with beat[ transplonm-
tion, there was a clear relation between preoperative hemo-
dynamic data and sabsegm^nt early morbidity or mortality .
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